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cular events (cardiovascular death, non-fatalmyocardial infarction [MI],
unstable angina pectoris, non-fatal ischemic stroke, hospitalization for
heart failure [HF] decompensation and coronary revascularization).
401 CAD patients were divided into low or high PP using a cutoff
value of 60 mm Hg as in previous reports and a median value of CAD
patients [7]. In consideration of the internal correlation between age
and estimated glomerular ﬁltration rate (eGFR), we made two models
for multiple regression analysis as shown in Table 1A. Age, female sex,
prevalence of hypertension and diabetes mellitus (DM), eGFR and ln-
B-type natriuretic peptide (BNP) were independently and signiﬁcantlyPulse pressure (PP), deﬁned as the difference between systolic blood
pressure (SBP) and diastolic blood pressure (DBP), is a marker for in-
creased large arterial stiffness [1], and is a major independent predictor
of cardiovascular mortality in both general and hypertensive popula-
tions [2]. Recent cohort studies have shown that elevated SBP is associ-
ated with increased risk of cardiovascular disease and predicts future
cardiovascular events in patients with coronary artery disease (CAD)
[3]. Furthermore, a “J-curve” was reported to exist for DBP for patients
with CAD but not for those with renal disease or stroke prevention [4].
Because both elevated SBP and decreased DBP augment PP values, we
hypothesized that PP could be amore useful riskmarker in CAD patients
than other blood pressure (BP) parameters.
A total of 999 consecutive stable patients with suspected CAD who
were referred to Kumamoto University Hospital between January
2007 and August 2013 for coronary angiography (CAG)were registered.
Based on the results of CAG, patients with organic coronary artery ste-
nosis (≥75%) were diagnosed as having CAD, and Gensini scores were
examined for evaluation of severity of CAD [5]. SBP, DBP and PP were
determined on admission using a device for ankle brachial index (ABI)
measurement (BP-203RPE II; Omron Colin, Tokyo, Japan). We deﬁned
peripheral artery disease (PAD) as ABI less than 0.9 in either leg, as
reported previously [6]. Patients were followed up prospectively atcular Medicine, Faculty of Life
University, 1-1-1 Honjo, Chuo-
amoto).
land Ltd. This is an open access articlour outpatient clinics until October 2014 or the occurrence of cardiovas-
associated with high PP in CAD patients (p = 0.02, p b 0.01, p = 0.01,
p b 0.01, p = 0.03 and p = 0.04, respectively, Table 1A), according to
multivariate logistic regression analysis with factors found signiﬁcant
by simple analysis.
During 90–1500 day (mean 1058 days) follow-up, 77 cardiovascular
events were recorded. Total cardiovascular events occurred more fre-
quently in CAD patients with high-PP than in those with low-PP
(p b 0.01). Kaplan–Meier analysis showed that CAD patients with
high-PP (n = 188) had a higher risk of cardiovascular events than
those with low-PP (n = 313) (log-rank test, p b 0.01, Fig. 1a). By
contrast, neither high SBP (N140 mm Hg) nor low DBP (b73 mm Hg;
median value of DBP) affected the occurrence of cardiovascular events
in CAD patients (Fig. 1a). By univariate Cox hazard analysis, nine
variables were identiﬁed as signiﬁcant predictors (high PP, body mass
index, hypertension, Gensini score, eGFR, ln-BNP, ABI, left atrium
diameter and the ratio of early transmitral ﬂow velocity to tissue dopp-
ler early diastolic mitral annular velocity). After excluding hypertension
andABI in consideration of the internal correlationwith PP,multivariate
Cox-hazard analysis including signiﬁcant predictors in simple Cox-
hazard analysis showed that high PP was an independent and
signiﬁcant predictor for cardiovascular events (hazard ratio: 1.75 and
1.71, 95% conﬁdence interval: 1.09–2.83 and 1.06–2.76, p = 0.02 and
p= 0.03, in model 1 andmodel 2, respectively, Table 1B). Furthermore,
by stratifying CAD patients according to combinations of PP and ABI
values, Kaplan–Meier analysis showed that high-PP with PAD
had higher risk of cardiovascular events than high-PP without PAD
(log-rank test, p b 0.001, Fig. 1b).
Aortic stiffness was reported to be an independent predictor of car-
diovascular events in various cardiovascular diseases, and Regnault
et al. recently demonstrated the clinical signiﬁcance of markers of aortice under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1A
Logistic regression analysis for high PP in CAD patients.
Variables Simple regression Multiple regression analysis model 1 Multiple regression analysis model 2
OR 95% CI p value OR 95% CI p value OR 95% CI p value
Age (per1) 1.04 1.02–1.06 b0.01 1.03 1.01–1.06 0.02 Not selected
Sex (male, yes) 0.34 0.22–0.53 b0.01 0.38 0.22–0.66 b0.01 0.37 0.21–0.64 b0.01
BMI (per1) 1.01 0.95–1.06 0.82
Hypertension (yes) 2.70 1.56–4.67 b0.01 2.32 1.29–4.17 0.01 2.30 1.28–4.16 0.01
DM (yes) 2.24 1.50–3.34 b0.01 2.43 1.57–3.76 b0.01 2.17 1.42–3.33 b0.01
Dyslipidemia (yes) 0.74 0.48–1.15 0.19
Smoking (yes) 0.67 0.45–0.99 0.05 1.14 0.68–1.91 0.61 1.12 0.67–1.87 0.67
Gensini score (per1) 1.01 0.99–1.01 0.09
eGFR (per1) 0.98 0.96–0.99 b0.01 Not selected 0.98 0.97–1.00 0.03
Ln-BNP (per1) 2.05 1.29–3.27 b0.01 1.72 1.03–2.87 0.04 1.84 1.12–3.02 0.02
Hosmer-Lemeshow χ2 P value 6.46
0.60
10.63
0.22
Model 1: signiﬁcant factors in simple regression analysis without eGFR.
Model 2: signiﬁcant factors in simple regression analysis without age.
PP: pulse pressure, CAD: coronary artery disease, OR: odds ratio, CI: conﬁdence interval, BMI: bodymass index, DM: diabetes mellitus, eGFR: estimated glomerular ﬁltration rate, BNP: B-
type natriuretic peptide.
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with reduced left ventricular (LV) ejection fraction [8]. In the present
study, high PP was independently associated with the prevalence of
coronary risk factors such as hypertension and DM. PP values were sig-
niﬁcantly and strongly correlated with PWV (correlation coefﬁcient:
r = 0.45, p b 0.001, data not shown), indicating close association of PP
and PWV in CAD patients.Fig. 1. Follow-up analysis. (a) Kaplan–Meier analysis for the probability of cardiovascular event
DBP groups. CAD patients were divided into two groups, using the median value of PP (60 mm
Meier analysis showed a signiﬁcantly higher probability of cardiovascular events in CADpatients
signiﬁcant differences in outcomes of CAD patients not only between low or high SBP, but also
events in CAD patients divided into three groups according to PP and ABI values. The high PP w
compared with normal group, †p b 0.01 compared with normal group. ‡p b 0.05 compared wiTheprognostic importance of SBP for various cardiovascular diseases
is well established, and SBP is now regarded as a more important pa-
rameter than DBP [9]. In CAD patients, however, decreased DBP has
the possibility to increase cardiovascular risk due to lowering perfusion
pressure of coronary circulation [4]. The present study suggested that
high PP, but neither high SBP nor low DBP, was a signiﬁcant and inde-
pendent predictor of cardiovascular events in CAD patients. By contrast,s in CAD patients with low- or high-PP groups, low- or high-SBP groups, and low- or high-
Hg), 140 mm Hg of SBP, and the median value of DBP (73 mm Hg), respectively. Kaplan–
with highPP than in thosewith low PP (log-rank test, p b 0.01). In contrast, therewere not
between low or high DBP. (b) Kaplan–Meier analysis for the probability of cardiovascular
ith PAD (ABI b 0.9) group had the highest probability of cardiovascular events. *p b 0.05
th high-PP without PAD group.
Table 1B
Cox proportional hazard model for future cardiovascular events in CAD patients.
Variables Simple regression Multiple regression analysis
model 1
Multiple regression analysis
model 2
Multiple regression with factors
previously reported coronary
risk factors
HR 95% CI p value HR 95% CI p value HR 95% CI p value HR 95% CI p value
Age (years, per1) 1.02 1.00–1.05 0.06 1.04 1.01–1.07 b0.01
Sex (male, yes) 0.66 0.42–1.05 0.08 0.49 0.29–0.86 0.01
BMI (per1) 1.07 1.01–1.13 0.01 1.07 1.01–1.03 0.02 1.06 1.01–1.13 0.03 1.01 0.94–1.08 0.81
SBP (N140 mmHg, yes) 1.41 0.90–2.20 0.14
PP (N60 mmHg, yes) 2.05 1.29–3.26 b0.01 1.75 1.09–2.83 0.02 1.71 1.06–2.76 0.03
DBP (b73 mmHg, yes) 0.64 0.71–1.74 0.64
Hypertension (yes) 2.19 1.06–4.57 0.04 2.87 1.42–5.80 b0.01
DM (yes) 1.14 0.73–1.79 0.55 2.07 1.31–3.28 b0.01
Dyslipidemia (yes) 0.77 0.48–1.25 0.29 0.57 0.34–0.96 0.03
Smoking (yes) 1.03 0.66–1.63 0.89 0.95 0.55–1.61 0.84
Gensini score (per1) 1.01 1.00–1.01 0.03 1.01 1.00–1.01 0.12 1.01 1.00–1.01 0.07
eGFR (per1) 0.98 0.97–0.99 0.01 0.99 0.97–1.00 0.10 0.98 0.97–1.00 0.02
LnBNP (per1) 1.82 1.04–3.20 0.04 1.47 0.81–2.68 0.21
ABI (per1) 0.12 0.04–0.32 b0.01
PWV (N1810 cm/s, yes) 0.97 0.62–1.52 0.91
LVEF (per1) 0.99 0.96–1.01 0.54
LVDd (per1) 0.99 0.95–1.03 0.49
LAD (per1) 1.04 1.00–1.08 0.03
E/e’ (per1) 1.06 1.01–1.11 0.03 1.03 0.98–1.09 0.25
Model 1: signiﬁcant factors in simple Cox proportional hazards analysis without hypertension, ABI and E/e’.
Model 2: signiﬁcant factors in simple Cox proportional hazards analysis without hypertension, ABI and ln-BNP.
HR: hazard ratio, SBP: systolic blood pressure, DBP: diastolic blood pressure, ABI: ankle brachial index, PWV: pulse wave velocity, LVEF: left ventricular ejection fraction, LVDd: left ven-
tricular diastolic diameter, LAD: left atrium diameter, E/e′: the ratio of early transmitral ﬂow velocity to tissue doppler early diastolic mitral annular velocity. Other abbreviations are as in
Table 1A.
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in Japanese participants after adjustment for SBP [10]. These studies also
included Japanese subjects, suggesting that the clinical signiﬁcance of
PP might differ according to the type of cardiovascular disease.
This study further demonstrated that CAD patients with a combina-
tion of high PP with low ABI had the highest risk of cardiovascular
events, suggesting that combining ABI to PP value could be a more
precise cardiovascular risk predictor in CAD patients. ABImeasurement,
determining PP and ABI values simultaneously, could be an important
non-invasive means of identifying patients with poor prognoses.
This study has several limitations. First, BP was measured by an ABI
device in the supine position, while standard BP measurement is made
in the seated position. PP values in this study may differ from ordinary
PP values. Second, many CAD patients take a variety of cardiovascular
agents, and the PP values could have been inﬂuenced by these medica-
tions. Third, we did not measure the LV stroke volume, although PP
values are generally inﬂuenced not only by aortic stiffness but also by
stroke volume. However, few old MI patients with poor LV function
were enrolled, thus most CAD patients had a certain level of cardiac
output. Despite these limitations, this study provides the stronger
prognostic signiﬁcance of PP than other BP measures in CAD patients.
In addition, combining PP to ABI values might further enhance the
prediction of cardiovascular risks.
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